185 related articles for article (PubMed ID: 9722128)
21. Fluoxetine's spectrum of action in premenstrual syndrome.
Menkes DB; Taghavi E; Mason PA; Howard RC
Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
[TBL] [Abstract][Full Text] [Related]
22. Fluoxetine in the treatment of premenstrual dysphoric disorder.
Carr RR; Ensom MH
Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
[TBL] [Abstract][Full Text] [Related]
25. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Wyatt KM; Dimmock PW; O'Brien PM
Cochrane Database Syst Rev; 2002; (4):CD001396. PubMed ID: 12519554
[TBL] [Abstract][Full Text] [Related]
27. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
Romano S; Judge R; Dillon J; Shuler C; Sundell K
Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
[TBL] [Abstract][Full Text] [Related]
28. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
29. SSRIs for premenstrual dysphoric disorder.
Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
31. Integrative treatments for premenstrual syndrome.
Low Dog T
Altern Ther Health Med; 2001; 7(5):32-9; quiz 40, 139. PubMed ID: 11565400
[No Abstract] [Full Text] [Related]
32. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
Silber TJ; Valadez-Meltzer A
J Adolesc Health; 2005 Dec; 37(6):518-25. PubMed ID: 16310133
[TBL] [Abstract][Full Text] [Related]
33. Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
Roca CA; Schmidt PJ; Smith MJ; Danaceau MA; Murphy DL; Rubinow DR
Am J Psychiatry; 2002 Nov; 159(11):1876-81. PubMed ID: 12411222
[TBL] [Abstract][Full Text] [Related]
34. Treating premenstrual dysphoric disorder using serotonin agents.
Lin J; Thompson DS
J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
[TBL] [Abstract][Full Text] [Related]
35. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Halbreich U; Smoller JW
J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
[TBL] [Abstract][Full Text] [Related]
36. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
Pearlstein T; Yonkers KA
Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
[TBL] [Abstract][Full Text] [Related]
37. Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Med Lett Drugs Ther; 2001 Jan; 43(1096):5-6. PubMed ID: 11177220
[No Abstract] [Full Text] [Related]
38. Role of bromocriptine and pyridoxine in premenstrual tension syndrome.
Sharma P; Kulshreshtha S; Singh GM; Bhagoliwal A
Indian J Physiol Pharmacol; 2007; 51(4):368-74. PubMed ID: 18476391
[TBL] [Abstract][Full Text] [Related]
39. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.
Mortola JF
Drug Saf; 1994 Feb; 10(2):160-9. PubMed ID: 8011181
[TBL] [Abstract][Full Text] [Related]
40. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
Freeman EW
CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
